Clene Inc (CLNN) Inventory Turnover Ratio, from second quarter 2026 to second quarter 2025, current and historic results, rankings and more, Quarterly Fundamentals - CSIMarket
CSIMarket Company Name, Ticker, Competitors, else..
 
Clene Inc   (NASDAQ: CLNN)
 

Clene Inc Inventory Turnover Ratio (COS)

Cost of Sales Formula, Quarterly Results, Trends, Rankings, Statistics

Clene Inc inventory turnover ratio, the Clene Inc 's ability to sell and replace its inventory in the second quarter 2026, sequentially increased to 1.25 in the second quarter 2026, yet the ratio remained below the average, as CLNN's market remain challenging.Average inventory processing period, for the Clene Inc in Jun 30 2026 quarter, has decreased to 292 days, compare to 913 days, in the Mar 31 2026 quarter.

Within Healthcare sector 289 other companies have achieved higher inventory turnover ratio. While Inventory turnover ratio total ranking has improved so far during the II Quarter 2026, to 1919, from total ranking in the first quarter 2026 at 2028.

CLNN Inventory Turnover Ratio using Sales Formula
What is Inventory Turnover Ratio?
What is Clene Inc Market Share?

What is Inventory Turnover Ratio?



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

CLNN Inventory Turnover Ratio (Jun 30 2026)
II. Quarter		 (Mar 31 2026)
I. Quarter		 (Dec 31 2025)
IV. Quarter		 (Sep 30 2025)
III. Quarter		 (Jun 30 2025)
II. Quarter
Y / Y Inventory Growth -53.16 % 42.11 % -45.59 % -52.34 % 113.51 %
Y / Y Cost of Sales Growth - - 27.78 % - -
Inventory Turnover Ratio (TTM) 1.25 - 0.8 - -
CLNN's Total Ranking # 1919 # 2028 # 1969 # 1961 # 1892
Average inventory processing period 292 - 456 - -
Seq. Inventory Growth -31.48 % 45.95 % -39.34 % -22.78 % 107.89 %
Seq. Cost of Sales Growth - - - - -




Inventory Turnover Ratio Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 80
Healthcare Sector # 290
Overall Market # 1919

Inventory Turnover Ratio Statistics
High Average Low
26.31 3.92 0.4
(Mar 31 2022)   (Mar 31 2026)



CLNN Company Profile >> Back to CLNN Efficiency Comparisons >> Compare CLNN Inventory Turnover Ratio to its Competitors

Financial Statements
Clene Inc 's Inventories $ 0 Millions Visit CLNN's Balance sheet
Clene Inc 's Cost of Revenues TTM $ 0 Millions Visit CLNN's Income Statement
What are CLNN's Sales? Visit CLNN's Sales by Segment

Other Inventory Turnover Ratios
Clene Inc 's Inventory to Sales Ratio
U.S. Durable Goods Inventory to Shipment Ratio By Product
Major Pharmaceutical Preparations Industry Inventory Turnover Trends and Statistics
Healthcare Sector Inventory Turnover Statistics
Inventory Turnover Trends for overall market
CLNN's Inventory Turnover Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Inventory Turnover
Lowest Ranking Inventory Turnover
Inventory Turnover for CLNN's Competitors
Inventory Turnover Ratio for CLNN's Suppliers
Inventory Turnover Ratio for CLNN's Customers

You may also want to know
CLNN's Sales Growth Rates CLNN's Pe Price to earnings ratio CLNN's Receivables Turnover Ratio CLNN's Stock Quote
CLNN's Net Income Growth Rates CLNN's Ps Price to Sales ratio CLNN's Sales per Employee CLNN's Asset Turnover Ratio
CLNN's Net Margin CLNN's Pb Price to Book ratio CLNN's Financial Strength Ratios CLNN's Dividend Payout Ratio



Companies with similar Inventory Turnover Ratio for the quarter ending Jun 30 2026, within Healthcare Sector Inventory Turnover Ratio Cost of revenues at quarter ending Jun 30 2026 Inventories at quarter ending Jun 30 2026
Adc Therapeutics Sa  4.17 $ 5.806  Millions$ 1  Millions
Scilex Holding Company  4.08 $ 14.867  Millions$ 4  Millions
Medinotec Inc   4.08 $ 4.736  Millions$ 1  Millions
3m Company  4.07 $ 15,258.000  Millions$ 3,754  Millions
Electromed Inc   4.02 $ 14.133  Millions$ 4  Millions
Novocure Limited  4.02 $ 166.921  Millions$ 41  Millions
Elite Pharmaceuticals Inc   3.95 $ 78.824  Millions$ 20  Millions
Lftd Partners Inc   3.89 $ 29.233  Millions$ 8  Millions
Pmgc Holdings Inc   3.87 $ 1.364  Millions$ 0  Millions
Intelligent Bio Solutions Inc   3.80 $ 2.165  Millions$ 1  Millions
Iridex Corp  3.80 $ 32.517  Millions$ 9  Millions
Teva Pharmaceutical Industries Limited  3.66 $ 8,232.000  Millions$ 2,250  Millions
Neuraxis Inc   3.55 $ 0.783  Millions$ 0  Millions
Beyond Air Inc   3.51 $ 6.447  Millions$ 2  Millions
Nexgel Inc   3.49 $ 7.577  Millions$ 2  Millions
Lifeward ltd   3.47 $ 13.976  Millions$ 4  Millions
Bellevue Life Sciences Acquisition Corp  3.38 $ 1.215  Millions$ 0  Millions
10x Genomics Inc   3.29 $ 184.539  Millions$ 56  Millions
Biofrontera Inc   3.28 $ 6.622  Millions$ 2  Millions
Maravai Lifesciences Holdings Inc   3.22 $ 135.038  Millions$ 42  Millions
Agilent Technologies inc   3.20 $ 3,404.000  Millions$ 1,064  Millions
Mettler toledo International Inc   3.18 $ 1,277.460  Millions$ 401  Millions
Bionexus Gene Lab Corp   3.15 $ 2.362  Millions$ 1  Millions
Eton Pharmaceuticals Inc   3.11 $ 44.176  Millions$ 14  Millions
Mimedx Group Inc   3.07 $ 75.981  Millions$ 25  Millions
Resmed Inc   2.97 $ 2,770.562  Millions$ 933  Millions
Msa Safety Inc  2.92 $ 1,021.036  Millions$ 350  Millions
Ligand Pharmaceuticals Incorporated  2.91 $ 32.387  Millions$ 11  Millions
Logicmark Inc  2.83 $ 3.881  Millions$ 1  Millions
Merck and Co Inc   2.79 $ 17,996.000  Millions$ 6,447  Millions

Date modified: 2026-08-17T17:20:50+00:00




Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.